AUG 26, 2021 10:44 PM PDT

Researchers View COVID-19 Progression in a Live Animal Model

WRITTEN BY: Carmen Leitch

Scientists have used a mouse model to visualize the progression of a SARS-CoV-2 infection as it led to sometimes fatal cases of COVID-19. The research indicated that human antibodies can help halt the infection before it starts or treat it after it's begun. But it also revealed that antibodies are only effective if they have the power to recruit killer cells from the immune system. The findings have been reported, now as a pre-proof, in the journal Immunity.

"For the first time, we were able to visualize the spread of the SARS-CoV-2 in a living animal in real time, and importantly, the sites at which antibodies need to exert effects to halt progression of infection," said co-corresponding study author Priti Kumar, an associate professor of infectious diseases at Yale School of Medicine.

Fluorescent tags and advanced microscopy techniques were used to see the viral particles at the single-cell level. In mice, the infection followed a course that's been seen in patients. The first cells with high viral loads were in the nose, then the infection moved through the respiratory tract to the lungs and then on to other organs. When the virus reached the brains of infected mice, they died.

Antibodies were collected from people that had recovered from COVID-19, and the researchers gave these antibodies to some of the infected mice. Even when the mice received the antibodies three days after they'd been exposed to the virus, the spread of the infection could be halted. If the mice got the antibodies prior to being exposed to the virus, the infection could be prevented completely.

However, not all of the antibodies were equally effective at stopping the virus. Antibodies can bind to viral particles to physically prevent them from latching onto cells and infecting them. They can also trigger other mechanisms in the immune system, which can lead to the destruction of the virus. The study indicated that the ability of antibodies to stimulate other immune system functions is crucial.

This transmission electron microscope image shows SARS-CoV-2-also known as 2019-nCoV, the virus that causes COVID-19. Virus particles are shown emerging from the surface of a cell cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. Image captured and colorized at Rocky Mountain Laboratories in Hamilton, Montana. Credit: NIAID

"In this study we show that their capacity to call for help from other cells in the immune system and eliminate infected cells is required to provide optimal protection," explained study co-author Andrés Finzi of the Université de Montréal.

This study has suggested that it's not enough for antibodies to neutralize infection by preventing binding; they also have to have other functions that will lead to the destruction of the virus.

Now that this tool can be used to quickly visualize the spread of the virus in a model, researchers can quickly evaluate the likelihood that treatments will be effective against SARS-CoV-2 infections or not, and in about four days. This rapid assessment technique could be useful now and in future pandemics, noted study co-author and Yale research scientist Pradeep Uchil.

Sources: Yale University, Immunity

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
FEB 17, 2022
Technology
Synthetic Human Nose Models Help Study Early Stages Of COVID Infection
FEB 17, 2022
Synthetic Human Nose Models Help Study Early Stages Of COVID Infection
The use of synthetic models replicating parts of the human body (often called “organoids”), has emerged in r ...
MAR 04, 2022
Drug Discovery & Development
COVID-19 Vaccines and Treatments Less Effective Against Omicron
MAR 04, 2022
COVID-19 Vaccines and Treatments Less Effective Against Omicron
mRNA COVID-19 vaccines and monoclonal antibody treatments are less effective against Omicron sub-variants of COVID-19 th ...
APR 03, 2022
Coronavirus
Another Study Shows Ivermectin Does Not Treat COVID-19
APR 03, 2022
Another Study Shows Ivermectin Does Not Treat COVID-19
A recent, large study has determined that ivermectin, an anti-parasitic drug, does not effectively reduce the risk of ho ...
JUN 10, 2022
Health & Medicine
Are Cardiac Complications More Common After COVID-19 Infection or Vaccination?
JUN 10, 2022
Are Cardiac Complications More Common After COVID-19 Infection or Vaccination?
Myocarditis was a well-known reported side effect of COVID-19 vaccines, but heart issues were also a reported symptom of ...
JUN 28, 2022
Cardiology
Unvaccinated Heart Failure Patients Face Major Risks
JUN 28, 2022
Unvaccinated Heart Failure Patients Face Major Risks
Unvaccinated heart failure patients are three times more likely to die if infected with COVID-19.
AUG 19, 2022
Coronavirus
Most Omicron-Infected People Are Unaware of Their Infection
AUG 19, 2022
Most Omicron-Infected People Are Unaware of Their Infection
Since the start of the pandemic, researchers and clinicians have warned that not everyone who is infected with SARS-CoV- ...
Loading Comments...